NCT05673681 Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry
| NCT ID | NCT05673681 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundación Academia Española de Dermatología |
| Condition | Melanoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 7,000 participants |
| Start Date | 2022-06-01 |
| Primary Completion | 2032-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 7,000 participants in total. It began in 2022-06-01 with a primary completion date of 2032-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this patient registry is to describe risk factors for bad prognosis of melanoma in Spain. The main questions it aims to answer are: * To describe socioeconomical individual risk factors associated with melanoma prognosis, such as gender, residence area or socioeconomic level. * To describe potentially modifiable characteristics of health care associated with prognosis, such as waiting times, type of centre that makes the diagnosis or use of teledermatology Participants data will be gathered for analysis, without any change in the way that they are being treated.
Eligibility Criteria
Inclusion Criteria: * All consecutive patients with a diagnosis of invasive primary cutaneous melanoma in participating centres. Exclusion Criteria: * In-situ melanomas * non-cutaneous melanomas, * metastatic melanoma with unknown primary site.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05673681 clinical trial?
This trial is open to participants of all sexes, studying Melanoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05673681 currently recruiting?
Yes, NCT05673681 is actively recruiting participants. Contact the research team at merce.grau@equipo.aedv.es for enrollment information.
Where is the NCT05673681 trial being conducted?
This trial is being conducted at Badalona, Spain, A Coruña, Spain, Barcelona, Spain, Córdoba, Spain and 11 additional locations.
Who is sponsoring the NCT05673681 clinical trial?
NCT05673681 is sponsored by Fundación Academia Española de Dermatología. The trial plans to enroll 7,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.